On February 24, PVMC became the first hospital in Colorado to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient. The smallest implantable cardiac monitoring device available was cleared by the U.S. Food and Drug Administration only the week before.
The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, heart palpitation, syncope (recurrent fainting), unexplained stroke, atrial fibrillation, and chest pain suggesting a cardiac arrhythmia (or irregular heartbeat). It is also used for patients at increased risk for cardiac arrhythmias.
“This device will help patients get their lives back, because it provides physicians with accurate, timely information as to whether or not their problems are heart related,” explains Interventional Cardiologist Qaisar Khan, M.D. FAAC of High Plains Heart and Vascular Center, who installed the first device in Colorado. “Using its advanced wireless technology, we are able to monitor our patients anywhere, anytime, to provide the care they need.”
The Reveal LINQ ICM is approximately one-third the size of a AAA battery, making it over 80 percent smaller than previously available cardiac monitors. While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than its larger predecessor, Reveal® XT.
In addition to its continuous and wireless monitoring capabilities, the system transmits patients’ cardiac diagnostic data remotely to their physician from nearly any location in the world through the Carelink® Network. Through the Network, physicians are alerted if their patients have had cardiac events. This ensures early and accurate diagnosis of irregular heartbeats, even when the patient is not physically in the hospital.
Placed just beneath the skin through a small incision of less than 1 cm in the upper left side of the chest, the monitor is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients.
Four devices were installed in our Cardiac Cath Lab on February 24. Dr. Khan installed two, and Electrophysiologist Christopher S. Stees, D.O., FACC, installed two.
“My patients came from Denver to Brighton to receive this device,” says Dr. Stees. “This procedure is less invasive for my patients and is a significant improvement over other monitoring devices. It’s an important, helpful step in diagnosing patients with abnormal heart rhythms.”
To learn more about how this device is changing lives, visit www.MonitorYourHeart.com. To learn more about the cardiologists at Platte Valley Medical Center using this new technology, visit www.hphvc.com.